Catalyst Wire Dossier Catalyst Wire Dossier

5-aminolevulinic acid hydrochloride (5-ALA hydrochloride)

5-aminolevulinic acid hydrochloride · medac GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-aminolevulinic acid hydrochloride (5-ALA hydrochloride), covering 2016-05-23 to 2016-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas [Phase 1, Phase 2]

See pricing